Aldara

Imiquimod

Designed to target viral or abnormal cell lesions and to alleviate site-specific skin conditions.

Category
Skin Care
Active ingredient
Imiquimod
Supply
Rx
Route
Cutaneous use
Form
Cream
Strengths
5%

Aldara details

Alternative names
Zyclara
Therapeutic class
Immunomodulator
Pharmacological class
Imidazoquinoline
Contraindications
hypersensitivity to imiquimod
Minor side effects
erythema; excoriation; scaling; oedema
Moderate side effects
erosion; ulceration; application site pain
Serious side effects
severe inflammatory reaction, requires immediate medical attention
Dosage forms
Cream
Administration route
Cutaneous use
Supply category
Prescription only (specially controlled medicine)
Manufacturer
Viatris
Onset Time
4–8 weeks
Duration
as prescribed
Storage instructions
Do not freeze; store below 25°C.
Age restrictions
Not for children unless specified.
Pregnancy and breastfeeding
Pregnancy: Consult doctor prior to use. Breastfeeding: Use with caution.
Precautions and warnings

avoid contact with eyes and mucous membranes; limit exposure to sunlight; do not apply to broken skin

Patient summary

designed to target viral or abnormal cell lesions and to alleviate site-specific skin conditions.

Mechanism of action

Functions as an immune response modifier, inducing the production of interferon-alpha and other cytokines to localise immune activity at the application site.

Where this medicine is registered

  • Singapore
  • Hong Kong
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Taiwan
  • South Korea
  • Japan
  • Australia
  • New Zealand
  • UAE
  • South Africa

About Aldara

Aldara is a topical brand of Imiquimod, an immune response modifier used to treat Actinic Keratosis, Superficial Basal Cell Carcinoma and Genital Warts. The same active ingredient is also sold under the brand name Zyclara. This medication is supplied in 5% strength sachets and produced by Viatris.

Buying Aldara online

Aldara is registered across 14 markets, making it one of the most ordered treatments of its type across the region, with deliveries managed for patients in Japan, the UAE and Singapore, as well as Hong Kong, Thailand and Malaysia. While the original Viatris version is widely recognised, generic Imiquimod, often produced in India, offers a far more affordable alternative for expats and residents who require reliable access to their medication regardless of local pharmacy stocks.